Document Detail


Long-term economic evaluation of resectoscopic endometrial ablation versus hysterectomy for the treatment of menorrhagia.
MedLine Citation:
PMID:  9782137     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
STUDY OBJECTIVE: To assess long-term costs of resectoscopic endometrial ablation versus hysterectomy in women with menorrhagia. DESIGN: Controlled cohort study (Canadian Task Force classification II-2). SETTING: Multispeciality group practice. PATIENTS: Sixty-four women who underwent endometrial ablation during 1992-1994 and 46 women who underwent hysterectomy during 1990-1992. To attain comparable controls, patients with uterine size exceeding 14 weeks or uterine weight greater than 300 g, ovarian pathology, endometriosis, or neoplasia were excluded. INTERVENTIONS: Endometrial ablation and hysterectomy, followed by economic evaluation. MEASUREMENTS AND MAIN RESULTS: Direct costs were hospitalization charges, professional fees, preoperative depot leuprolide, and gynecologic care during 3 years after primary surgery. Indirect costs were calculated based on known demographic data, recovery time, and lost productivity. Surgical outcomes, complications, repeat surgeries, menstrual outcomes, and overall patient satisfaction were assessed. Operating time (38 vs 107 min), hospital stay (0.7 vs 2.7 days), frequency of postoperative complications (6.3% vs 21.7%), and recuperation time (5 vs 32 days) were less with endometrial ablation than with hysterectomy. Mean follow-up was 48.5 months (range 36-68 mo), with rates of amenorrhea, hypomenorrhea, and eumenorrhea of 49%, 29%, and 8%, respectively. One patient was lost to follow-up. There were eight failures (12%): repeat endometrial ablations (2 women), abdominal hysterectomy (1), and laparoscopic-assisted hysterectomy (5). Most women (85%) remained satisfied with the operation. Total direct costs/case for endometrial ablation were $5434 versus $8417 for hysterectomy; respective indirect costs/case were $525 and $3360. Conclusion. Long-term direct and indirect costs of endometrial ablation were significantly less than those of hysterectomy ($5959 vs $11,777) for the treatment of menorrhagia.
Authors:
D A Hidlebaugh; R K Orr
Related Documents :
11447737 - Regression of ovarian enlargement in pharmacological ovulation induction.
12052587 - Five-year follow-up of endometrial ablation: endometrial coagulation versus endometrial...
8633667 - Endometrial ablation: a series of 568 patients treated over an 11-year period.
14557437 - Contraceptive efficacy of a depot progestin and androgen combination in men.
24236427 - Evaluating the effectiveness of spleen autotransplantation into the liver and the omentum.
2887897 - Fate of the vascular patient after below-knee amputation.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  The Journal of the American Association of Gynecologic Laparoscopists     Volume:  5     ISSN:  1074-3804     ISO Abbreviation:  J Am Assoc Gynecol Laparosc     Publication Date:  1998 Nov 
Date Detail:
Created Date:  1999-01-29     Completed Date:  1999-01-29     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9417443     Medline TA:  J Am Assoc Gynecol Laparosc     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  351-6     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, Fallon Clinic and Saint Vincent Hospital, Worcester, Massachusetts, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Catheter Ablation / economics*,  methods
Cohort Studies
Costs and Cost Analysis
Female
Humans
Hysterectomy / economics*
Hysteroscopy / economics*
Menorrhagia / surgery*
Middle Aged
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine ...
Next Document:  Does preoperative treatment with a gonadotropin-releasing hormone agonist improve the outcome of end...